本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aligos Therapeutics, Inc.

8.00
+0.980013.96%
成交量:7.66萬
成交額:56.95萬
市值:4,922.88萬
市盈率:-0.82
高:8.03
開:6.95
低:6.94
收:7.02
52周最高:46.80
52周最低:3.76
股本:615.36萬
流通股本:300.20萬
量比:1.56
換手率:2.55%
股息:- -
股息率:- -
每股收益(TTM):-9.7606
每股收益(LYR):-20.9448
淨資產收益率:-141.82%
總資產收益率:-54.70%
市淨率:0.69
市盈率(LYR):-0.38

資料載入中...

2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/25

重要事件披露

Form 8-K - Current report
2023/11/23

SEC問詢函

Form CORRESP - Correspondence
2023/11/23

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/06

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/18

重要事件披露

Form 8-K - Current report
2023/09/07

重要事件披露

Form 8-K - Current report
2023/08/03

重要事件披露

Form 8-K - Current report